Oral drug blocks SARS-CoV-2 transmission
Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers
Read more
Decline in SARS-CoV-2 Antibody Response Seen Over 60 Days
MONDAY, Nov. 30, 2020 — More than one-quarter of health care personnel who were positive for severe acute respiratory syndrome
Read more
SARS-CoV-2 mutations do not appear to increase transmissibility
None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a
Read more
Covid-19: Features that could make someone coronavirus super-spreader identified
Using computer-generated models, scientists have simulated sneezes in different types of people, and identified the biological features that could make
Read more
AAP Urges Inclusion of Children in SARS-CoV-2 Vaccine Trials
WEDNESDAY, Nov. 18, 2020 — Children should be included in clinical trials for a severe acute respiratory syndrome coronavirus 2
Read more
Rate of Asymptomatic SARS-CoV-2 High Among Grocery Store Workers
FRIDAY, Oct. 30, 2020 — The rate of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is high among
Read more
Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs
INDIANAPOLIS, Oct. 7, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced additional details on its SARS-CoV-2 neutralizing antibody programs –
Read more
China’s experimental Covid-19 vaccine appears safe, no adverse reactions: Study
A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences
Read more
Hydroxychloroquine does not inhibit SARS-CoV-2 infection in preclinical models
An international collaboration of researchers across more than 80 countries has come to the conclusion that chloroquine (CQ) and hydroxchloroquine
Read more
Researchers find clues to SARS-CoV-2 infection, why it impacts patients differently
Working together, researchers at McMaster University and the University of Waterloo are searching for how the SARS-CoV-2 virus infects the
Read more